Cite

HARVARD Citation

    Moulton, C. et al. (2021). SITAgliptin for Depressive Symptoms in Type 2 Diabetes: A Feasibility Randomized Controlled Trial. Psychosomatic medicine. 83 (8), pp. 913-923. [Online]. 
  
Back to record